Kingdon Diagnostics - QBR
Documentfinal Kingdon Diagnostics · qbr_deck · final · 2025-05-26
A BB-Demo quarterly review for a Growth tier customer since 6 Jan 2025, written by Marcus Bell. It reports rising adoption from a small base, 40 licensed users and a clean support record. The term it cites ends 5 Jan 2026, so the deck is out of date.
What it says
What this says
Current to 13 Oct 26A BB-Demo quarterly review for a Growth tier customer since 6 Jan 2025, written by Marcus Bell. It reports rising adoption from a small base, 40 licensed users and a clean support record. The term it cites ends 5 Jan 2026, so the deck is out of date.
What it is: a customer success review dated 26 May 2025, prepared by Marcus Bell. It states "Contracted annual recurring revenue: £42k" and 40 licensed users, with roughly seven active in the last month.
Commits: nothing contractual. It sets a plan for next quarter: a session for contract managers who have not logged in, question counts by trust, and a discussion of extra capacity once usage supports it.
Unusual: nothing off the standard terms. The deck says "No renewal risk is showing today", but also that "Usage is concentrated in a small group of people".
Not settled: the deck is a point-in-time view and carries no service-level figures. The evidence does not show whether the 5 Jan 2026 renewal happened, nor whether Lewis Kerr, named as account owner, is still in post. The £42k figure should be checked against the executed order form and invoices.
As found in this document
Current to 9 Oct 26- Date end5 Jan 2026Source: object_read:doc_083_009
- Date renewal5 Jan 2026Source: object_read:doc_083_009
- Date start6 Jan 2025Source: object_read:doc_083_009
The document
Body
Kingdon Diagnostics - QBR
Quarterly business review prepared by Marcus Bell, Customer Success Manager, BB-Demo. Review date: 26 May 2025. Account owner: Lewis Kerr.
1. Where we are
- Customer since 6 Jan 2025, on the Growth tier.
- Contracted annual recurring revenue: £42k.
- Licensed users: 40.
- Current term ends 5 Jan 2026.
- Kingdon Diagnostics runs MRI and CT services for NHS trusts and private insurers from twelve sites in the North East and Cumbria. The brain was bought so that contract managers can see each trust's referrals, reporting-turnaround tickets and invoices in one place.
2. Usage this quarter
| Measure | Position |
|---|---|
| Average active users over the last month | Roughly seven |
| Change in active users against the previous quarter | Up by well over half |
| Licensed users | 40 |
- Adoption is growing from a small base. Only a minority of the licensed seats are in regular use, which leaves plenty of headroom inside the current licence.
- The growth comes mostly from contract managers, which is the audience the account was bought for.
- A larger share of the 40 seats being used is the main thing to work on over the next quarter.
Read the whole document (2,781 characters)
3. Value being seen
- Contract managers can look at one trust's referrals, turnaround tickets and invoices together instead of reconciling them by hand.
- Questions asked of the brain are the best measure of value. We will bring the month-on-month question counts to the next review so the value case is written down, not assumed.
4. Support and service
- One ticket in the last thirty days.
- No high-priority tickets.
- No overdue invoices.
- Nothing outstanding against the Growth service levels.
5. Risks and watch points
- No renewal risk is showing today: usage is up, payments are on time and support has been quiet.
- Usage is concentrated in a small group of people. We should widen it across the contract management team so the brain does not depend on a few individuals.
- The renewal date of 5 Jan 2026 is some months away. We will keep it on the agenda at each review.
6. Plan for next quarter
| Action | Owner | Timing |
|---|---|---|
| Run a short session for contract managers who have not yet logged in | Marcus Bell | Next month |
| Share question counts and example answers by trust | Marcus Bell | Before the next review |
| Agree which additional teams could use the brain | Marcus Bell with the customer sponsor | Before the next review |
| Discuss any extra capacity once usage supports it | Lewis Kerr | After the next review |
7. Summary
A healthy account with rising adoption and a clean support record. The priority is to turn that early momentum into regular daily use across the contract management team ahead of the renewal on 5 Jan 2026.